Actively Recruiting
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
Led by H. Lee Moffitt Cancer Center and Research Institute · Updated on 2026-02-09
125
Participants Needed
2
Research Sites
196 weeks
Total Duration
On this page
Sponsors
H
H. Lee Moffitt Cancer Center and Research Institute
Lead Sponsor
U
United States Department of Defense
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study will evaluate obesity-mediated mechanisms of pancreatic carcinogenesis in minority populations.
CONDITIONS
Official Title
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years of age or older at time of signing informed consent
- Patients who self-report as African American or Non-Hispanic White
- Patients presenting to gastrointestinal clinic, surgery, or endoscopy at participating Florida Pancreas Collaborative or University of Mississippi Medical Center with clinical suspicion or diagnosis of pancreatic tumor
You will not qualify if you...
- Under 18 years of age
- No suspicion or diagnosis of pancreatic cancer or tumor
- Self-reported race/ethnicity other than African American or Non-Hispanic White
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Moffitt Cancer Center
Tampa, Florida, United States, 33612
Actively Recruiting
2
University of Mississippi Medical Center
Jackson, Mississippi, United States, 39216
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here